Free Trial
Notice: An IPO for DGX is planned for Monday, December 30, 2024

Quest Diagnostics (DGX) Earnings Date, Estimates & Call Transcripts

Quest Diagnostics logo
$153.10 +1.58 (+1.04%)
(As of 12/20/2024 05:16 PM ET)

Quest Diagnostics Latest Earnings Summary

Actual EPS
(Oct. 22)
$2.30 Beat By $0.04
Consensus EPS
(Oct. 22)
$2.26

Quest Diagnostics issued Q3 2024 earnings on October 22, 2024, reporting an EPS of $2.30, which beat analysts' consensus estimates of $2.26 by $0.04. Quarterly revenue rose 8.5% year-over-year to $2.49 billion, above the consensus estimate of $2.43 billion. With a trailing EPS of $7.44 and a P/E Ratio of 20.58, Quest Diagnostics' earnings are expected to grow 8.99% next year, from $8.90 to $9.70 per share.

Get Quest Diagnostics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Quest Diagnostics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

DGX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

DGX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Quest Diagnostics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20243$1.84$2.17$1.96 
Q2 20243$2.29$2.32$2.30 
Q3 20243$2.26$2.32$2.29 
Q4 20243$2.17$2.20$2.19 
FY 202412$8.56$9.01$8.74 
Q1 20253$2.17$2.23$2.19 
Q2 20253$2.43$2.59$2.51 
Q3 20253$2.48$2.50$2.49 
Q4 20253$2.38$2.62$2.50 
FY 202512$9.46$9.94$9.70 
Q1 20261$2.60$2.60$2.60 
Q2 20261$2.62$2.62$2.62 
Q3 20261$2.61$2.61$2.61 

Quest Diagnostics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
10/22/2024Q3 2024$2.26$2.30+$0.04$2.61$2.43B$2.49B
7/23/2024Q2 2024$2.31$2.35+$0.04$2.67$2.39B$2.40B
4/23/2024Q1 2024$1.86$2.04+$0.18$2.36$2.29B$2.37B
2/1/2024Q4 2023$2.11$2.15+$0.04$2.60$2.25B$2.29B
10/24/2023Q3 2023$2.19$2.22+$0.03$2.48$2.27B$2.30B
7/26/2023Q2 2023$2.23$2.30+$0.07$2.55$2.25B$2.34B
We recommended Palantir in 2021, now we’re recommending this... (Ad)

My research indicates there is only one investment that can meet AI's unprecedented demand for energy.

Click to get the name and ticker symbol
4/27/2023Q1 2023$1.97$2.04+$0.07$2.30$2.20B$2.33B
2/2/2023Q4 2022$1.90$1.98+$0.08$3.09$2.26B$2.33B

Quest Diagnostics Earnings - Frequently Asked Questions

Quest Diagnostics (NYSE:DGX) last announced its quarterly earning data on Tuesday, October 22, 2024. Learn more on DGX's earnings history.

Quest Diagnostics issued an update on its FY24 earnings guidance on Tuesday, October, 22nd. The company provided earnings per share (EPS) guidance of $8.85-$8.95 for the period, compared to the consensus earnings per share estimate of $8.89. The company issued revenue guidance of $9.80-$9.85 billion, compared to the consensus revenue estimate of $9.68 billion.

In the previous quarter, Quest Diagnostics (NYSE:DGX) reported $2.30 earnings per share (EPS) to beat the analysts' consensus estimate of $2.26 by $0.04. Learn more on analysts' earnings estimate vs. DGX's actual earnings.

The conference call for Quest Diagnostics's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Quest Diagnostics's latest earnings report can be read online.
Read Transcript

Quest Diagnostics's earnings report can be found in their filing with the SEC.
View SEC filing

Quest Diagnostics (NYSE:DGX) has a recorded annual revenue of $9.54 billion.

Quest Diagnostics (NYSE:DGX) has a recorded net income of $854 million. DGX has generated $7.44 earnings per share over the last four quarters.

Quest Diagnostics (NYSE:DGX) has a trailing price-to-earnings ratio of 20.58 and a forward price-to-earnings ratio of 17.20. The price/earnings-to-growth ratio is 2.69.

Quest Diagnostics's earnings are expected to grow from $8.90 per share to $9.70 per share in the next year, which is a 8.99% increase.

More Earnings Resources from MarketBeat



This page (NYSE:DGX) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners